Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Carlisle Prices Notes Offering, To Repay Debts With Proceeds

Published 02/16/2020, 08:51 PM
Updated 07/09/2023, 06:31 AM
DOV
-
CSL
-
GFF
-
GGG
-

Carlisle Companies Incorporated (NYSE:CSL) , on Feb 13, announced the pricing of $750 million worth of senior notes. Subject to the fulfilment of customary conditions, the public offering of notes is expected to close on Feb 28, 2020.

It is worth mentioning here that the company’s shares gained 1% last Friday, ending the trading session at $163.31.

Inside the Headlines

As mentioned, the notes — due to expire on Mar 1, 2030, and carrying a coupon rate of 2.750% — have been offered at 98.756% of the principal amount. Interest on notes will be paid semi-annually, each on Mar 1 and Sep 1. The first interest payment will be made on Sep 1, 2020.

Notably, the issuer has the option to redeem wholly or in parts the senior notes, prior to Dec 1, 2029.

Carlisle will use funds raised from the notes offering to redeem 5.125% senior notes that are due to expire in 2020. Also, the company may use the funds for general corporate purposes (that includes payment of buyout-related expenses).

We believe that offerings of senior notes will increase the company’s debts and in turn, might inflate its financial obligations and hurt profitability. However, measures relating to redeeming notes will be a relief.

Carlisle’s Debt Profile

The company has a highly leveraged balance sheet. At the end of 2019, the company’s long-term debts were at $1,341.4 million. Its interest expenses totaled $66.1 million in the year, reflecting 2.2% increase from the previous year.

In February 2020, the company amended and extended credit facility worth $1 billion. The facility will mature in 2025. The proceeds from this facility will be used for acquisitions, repaying existing debts, capital spending, general corporate purposes and others.

Zacks Rank, Estimate Trend and Price Performance

With a market capitalization of $9.1 billion, Carlisle currently carries a Zacks Rank #4 (Sell). In the past 30 days, the Zacks Consensus Estimate for its earnings has been lowered by 1% to $8.96 for 2020 and raised by 2.2% to $10.07 for 2021.

Carlisle Companies Incorporated Price and Consensus

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Carlisle Companies Incorporated price-consensus-chart | Carlisle Companies Incorporated Quote

In the past three months, the company’s share price has increased 1.3% against the industry’s growth of 5.1%.





Stocks to Consider

Three better-ranked stocks are Griffon Corporation (NYSE:GFF) , Graco Inc. (NYSE:GGG) and Dover Corporation (NYSE:DOV) . While both Griffon and Graco currently sport a Zacks Rank #1 (Strong Buy), Dover carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

In the past 60 days, earnings estimates for these stocks have improved for the current year. Further, positive earnings surprise for the last four quarters, on average, was 20.34% for Griffon, 0.40% for Graco and 5.36% for Dover.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Graco Inc. (GGG): Free Stock Analysis Report

Dover Corporation (DOV): Free Stock Analysis Report

Carlisle Companies Incorporated (CSL): Free Stock Analysis Report

Griffon Corporation (GFF): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.